PSA set to launch renewed vision for profession at national conference

The Pharmaceutical Society of Australia (PSA) is thrilled to announce Pharmacists in 2030, its vision for the future of the pharmacy profession, will be launched this weekend at the PSA24 National Conference by Federal Health Minister, the Hon. Mark Butler MP.

A culmination of deep consultation with pharmacists, consumers and other health stakeholders, Pharmacists in 2030 describes how the care pharmacists provide will change over the next 6 years through the lens of both pharmacists and patients.

“The release of Pharmacists in 2023 back in 2019 was the first time that a clear vision and framework was developed to unlock the full potential of pharmacists in supporting the health and wellbeing of Australians,” said PSA National President, Associate Professor Fei Sim FPS.

“Hand-in-glove with the profession we have realised much of this vision, but there is still a long way to go.

We are now set to launch the next phase of this vision, Pharmacists in 2030, cementing the core role of pharmacists in medicines expertise and emphasising the ability of pharmacists to improve patient care.

“The growing expectations of our patients came through very strongly in our consumer consultation. Consumers have a very high level of trust in pharmacists, and they want us to do more.

“As the health needs of Australians continue to grow and become more complex, it is critical that our profession grows too. Pharmacists in 2030 is a roadmap that will guide the path forward to 2030, and beyond,” Associate Professor Sim concluded.

The launch of Pharmacists in 2030 will be a highlight of the PSA24 National Conference, where attendees will hear from national and global pharmacy leaders and connect with pharmacy colleagues from around Australia.

Must Read

New pharmacy standard to support patients through transitions of care

0
Advanced Pharmacy Australia (AdPha)’s Standard of practice for pharmacy services specialising in transitions of care guides best practice pharmacy care in the higher risk...